speb/financial-data huggingface dataset:
CCL income_statement (annual, 2022-11-30) — Tax Rate For Calcs: 0.21
CCL balance_sheet (annual, 2022-11-30) — Total Assets: 51703000000.00
CCL balance_sheet (annual, 2022-11-30) — Total Capitalization: 39017000000.00
CCL balance_sheet (annual, 2022-11-30) — Total Debt: 35881000000.00
CCL balance_sheet (annual, 2022-11-30) — Total Equity Gross Minority Interest: 7064000000.00
CCL income_statement (annual, 2022-11-30) — Total Expenses: 16547000000.00
CCL balance_sheet (annual, 2022-11-30) — Total Liabilities Net Minority Interest: 44639000000.00
CCL balance_sheet (annual, 2022-11-30) — Total Non Current Assets: 44211000000.00
CCL balance_sheet (annual, 2022-11-30) — Total Non Current Liabilities Net Minority Interest: 34034000000.00
CCL income_statement (annual, 2022-11-30) — Total Operating Income As Reported: -4379000000.00
CCL income_statement (annual, 2022-11-30) — Total Unusual Items: -1000000.00
CCL income_statement (annual, 2022-11-30) — Total Unusual Items Excluding Goodwill: -1000000.00
CCL balance_sheet (annual, 2022-11-30) — Treasury Shares Number: 202000000.00
CCL balance_sheet (annual, 2022-11-30) — Treasury Stock: 8468000000.00
CCL balance_sheet (annual, 2022-11-30) — Working Capital: -3113000000.00
CCL income_statement (annual, 2023-11-30) — +Operating Expense: 5320000000.00
CCL income_statement (annual, 2023-11-30) — +Total Revenue: 21593000000.00
CCL balance_sheet (annual, 2023-11-30) — Accounts Payable: 1168000000.00
CCL balance_sheet (annual, 2023-11-30) — Accounts Receivable: 556000000.00
CCL balance_sheet (annual, 2023-11-30) — Accumulated Depreciation: -20407000000.00
CCL balance_sheet (annual, 2023-11-30) — Additional Paid In Capital: 16712000000.00
CCL cash_flow (annual, 2023-11-30) — Asset Impairment Charge: 21000000.00
CCL income_statement (annual, 2023-11-30) — Average Dilution Earnings: 0.00
CCL income_statement (annual, 2023-11-30) — Basic Average Shares: 1262000000.00
CCL income_statement (annual, 2023-11-30) — Basic EPS: -0.06
CCL cash_flow (annual, 2023-11-30) — Beginning Cash Position: 6037000000.00
CCL cash_flow (annual, 2023-11-30) — Capital Expenditure: -3284000000.00
CCL balance_sheet (annual, 2023-11-30) — Capital Lease Obligations: 1319000000.00
CCL balance_sheet (annual, 2023-11-30) — Capital Stock: 373000000.00
CCL balance_sheet (annual, 2023-11-30) — Cash And Cash Equivalents: 2415000000.00
CCL balance_sheet (annual, 2023-11-30) — Cash Cash Equivalents And Short Term Investments: 2415000000.00
CCL balance_sheet (annual, 2023-11-30) — Cash Equivalents: 2415000000.00
CCL cash_flow (annual, 2023-11-30) — Cash Flow From Continuing Financing Activities: -5089000000.00
CCL cash_flow (annual, 2023-11-30) — Cash Flow From Continuing Investing Activities: -2810000000.00
CCL cash_flow (annual, 2023-11-30) — Cash Flow From Continuing Operating Activities: 4280000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Account Payable: 77000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Accrued Expense: 147000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Inventory: -85000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Other Working Capital: 1169000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Payable: 77000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Payables And Accrued Expense: 224000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Prepaid Assets: 397000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Receivables: -180000000.00
CCL cash_flow (annual, 2023-11-30) — Change In Working Capital: 1525000000.00
CCL cash_flow (annual, 2023-11-30) — Changes In Cash: -3618000000.00
CCL balance_sheet (annual, 2023-11-30) — Common Stock: 373000000.00
CCL balance_sheet (annual, 2023-11-30) — Common Stock Equity: 6883000000.00
CCL cash_flow (annual, 2023-11-30) — Common Stock Issuance: 5000000.00
CCL balance_sheet (annual, 2023-11-30) — Construction In Progress: 1284000000.00
CCL income_statement (annual, 2023-11-30) — Cost Of Revenue: 14317000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Accrued Expenses: 2003000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Assets: 5266000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Capital Lease Obligation: 149000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Debt: 2089000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Debt And Capital Lease Obligation: 2238000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Deferred Liabilities: 6072000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Deferred Revenue: 6072000000.00
CCL balance_sheet (annual, 2023-11-30) — Current Liabilities: 11481000000.00
CCL cash_flow (annual, 2023-11-30) — Depreciation Amortization Depletion: 2370000000.00
CCL income_statement (annual, 2023-11-30) — Depreciation Amortization Depletion Income Statement: 2370000000.00
CCL cash_flow (annual, 2023-11-30) — Depreciation And Amortization: 2370000000.00
CCL income_statement (annual, 2023-11-30) — Depreciation And Amortization In Income Statement: 2370000000.00
CCL income_statement (annual, 2023-11-30) — Diluted Average Shares: 1262000000.00
CCL income_statement (annual, 2023-11-30) — Diluted EPS: -0.06
CCL income_statement (annual, 2023-11-30) — Diluted NI Availto Com Stockholders: -74000000.00
CCL income_statement (annual, 2023-11-30) — EBIT: 2004000000.00
CCL income_statement (annual, 2023-11-30) — EBITDA: 4374000000.00
CCL cash_flow (annual, 2023-11-30) — Earnings Losses From Equity Investments: 13000000.00
CCL cash_flow (annual, 2023-11-30) — Effect Of Exchange Rate Changes: 17000000.00
CCL cash_flow (annual, 2023-11-30) — End Cash Position: 2436000000.00
CCL cash_flow (annual, 2023-11-30) — Financing Cash Flow: -5089000000.00
CCL balance_sheet (annual, 2023-11-30) — Foreign Currency Translation Adjustments: -1952000000.00
CCL cash_flow (annual, 2023-11-30) — Free Cash Flow: 997000000.00
CCL cash_flow (annual, 2023-11-30) — Gain Loss On Sale Of PPE: -88000000.00
CCL balance_sheet (annual, 2023-11-30) — Gains Losses Not Affecting Retained Earnings: -1938000000.00
CCL balance_sheet (annual, 2023-11-30) — Goodwill: 579000000.00
CCL balance_sheet (annual, 2023-11-30) — Goodwill And Other Intangible Assets: 1748000000.00
CCL balance_sheet (annual, 2023-11-30) — Gross PPE: 61788000000.00
CCL income_statement (annual, 2023-11-30) — Gross Profit: 7276000000.00
CCL income_statement (annual, 2023-11-30) — Impairment Of Capital Assets: 0.00
CCL income_statement (annual, 2023-11-30) — Interest Expense: 2066000000.00
CCL income_statement (annual, 2023-11-30) — Interest Expense Non Operating: 2066000000.00
CCL income_statement (annual, 2023-11-30) — Interest Income: 233000000.00
CCL income_statement (annual, 2023-11-30) — Interest Income Non Operating: 233000000.00
CCL balance_sheet (annual, 2023-11-30) — Inventory: 528000000.00
CCL balance_sheet (annual, 2023-11-30) — Invested Capital: 37455000000.00
CCL cash_flow (annual, 2023-11-30) — Investing Cash Flow: -2810000000.00
CCL cash_flow (annual, 2023-11-30) — Issuance Of Capital Stock: 5000000.00
CCL cash_flow (annual, 2023-11-30) — Issuance Of Debt: 2961000000.00
CCL balance_sheet (annual, 2023-11-30) — Line Of Credit: 0.00
CCL balance_sheet (annual, 2023-11-30) — Long Term Capital Lease Obligation: 1170000000.00
CCL balance_sheet (annual, 2023-11-30) — Long Term Debt: 28483000000.00
CCL balance_sheet (annual, 2023-11-30) — Long Term Debt And Capital Lease Obligation: 29653000000.00
CCL cash_flow (annual, 2023-11-30) — Long Term Debt Issuance: 2961000000.00
CCL cash_flow (annual, 2023-11-30) — Long Term Debt Payments: -7660000000.00
CCL balance_sheet (annual, 2023-11-30) — Machinery Furniture Equipment: 55026000000.00
CCL balance_sheet (annual, 2023-11-30) — Minimum Pension Liabilities: -34000000.00
CCL cash_flow (annual, 2023-11-30) — Net Business Purchase And Sale: 0.00
CCL cash_flow (annual, 2023-11-30) — Net Common Stock Issuance: 5000000.00
CCL balance_sheet (annual, 2023-11-30) — Net Debt: 28157000000.00
CCL income_statement (annual, 2023-11-30) — Net Income: -74000000.00
CCL income_statement (annual, 2023-11-30) — Net Income Common Stockholders: -74000000.00
CCL income_statement (annual, 2023-11-30) — Net Income Continuous Operations: -75000000.00
CCL income_statement (annual, 2023-11-30) — Net Income From Continuing And Discontinued Operation: -74000000.00
CCL income_statement (annual, 2023-11-30) — Net Income From Continuing Operation Net Minority Interest: -74000000.00
CCL cash_flow (annual, 2023-11-30) — Net Income From Continuing Operations: -74000000.00
CCL income_statement (annual, 2023-11-30) — Net Income Including Noncontrolling Interests: -75000000.00
CCL income_statement (annual, 2023-11-30) — Net Interest Income: -1833000000.00
CCL cash_flow (annual, 2023-11-30) — Net Investment Purchase And Sale: 0.00
CCL cash_flow (annual, 2023-11-30) — Net Issuance Payments Of Debt: -4899000000.00
CCL cash_flow (annual, 2023-11-30) — Net Long Term Debt Issuance: -4699000000.00
CCL income_statement (annual, 2023-11-30) — Net Non Operating Interest Income Expense: -1833000000.00
CCL cash_flow (annual, 2023-11-30) — Net Other Financing Charges: -190000000.00
CCL cash_flow (annual, 2023-11-30) — Net Other Investing Changes: 134000000.00
CCL balance_sheet (annual, 2023-11-30) — Net PPE: 41381000000.00
CCL cash_flow (annual, 2023-11-30) — Net PPE Purchase And Sale: -2944000000.00
CCL cash_flow (annual, 2023-11-30) — Net Short Term Debt Issuance: -200000000.00
CCL balance_sheet (annual, 2023-11-30) — Net Tangible Assets: 5135000000.00
CCL income_statement (annual, 2023-11-30) — Normalized EBITDA: 4485000000.00
CCL income_statement (annual, 2023-11-30) — Normalized Income: 13690000.00
CCL cash_flow (annual, 2023-11-30) — Operating Cash Flow: 4281000000.00
CCL cash_flow (annual, 2023-11-30) — Operating Gains Losses: 10000000.00
CCL income_statement (annual, 2023-11-30) — Operating Income: 1956000000.00
CCL income_statement (annual, 2023-11-30) — Operating Revenue: 21593000000.00
CCL balance_sheet (annual, 2023-11-30) — Ordinary Shares Number: 1264000000.00
CCL balance_sheet (annual, 2023-11-30) — Other Current Assets: 1756000000.00
CCL balance_sheet (annual, 2023-11-30) — Other Current Borrowings: 2089000000.00
CCL balance_sheet (annual, 2023-11-30) — Other Equity Adjustments: 48000000.00
CCL income_statement (annual, 2023-11-30) — Other Income Expense: -186000000.00
CCL balance_sheet (annual, 2023-11-30) — Other Intangible Assets: 1169000000.00
CCL cash_flow (annual, 2023-11-30) — Other Non Cash Items: 397000000.00
CCL balance_sheet (annual, 2023-11-30) — Other Non Current Assets: 725000000.00
CCL balance_sheet (annual, 2023-11-30) — Other Non Current Liabilities: 1103000000.00
CCL income_statement (annual, 2023-11-30) — Other Non Operating Income Expenses: -75000000.00
CCL balance_sheet (annual, 2023-11-30) — Other Properties: 5478000000.00
CCL income_statement (annual, 2023-11-30) — Other Special Charges: 111000000.00
CCL balance_sheet (annual, 2023-11-30) — Payables: 1168000000.00
CCL balance_sheet (annual, 2023-11-30) — Payables And Accrued Expenses: 3171000000.00
CCL income_statement (annual, 2023-11-30) — Pretax Income: -62000000.00
CCL cash_flow (annual, 2023-11-30) — Proceeds From Stock Option Exercised: 2000000.00
CCL cash_flow (annual, 2023-11-30) — Purchase Of Business: 0.00
CCL cash_flow (annual, 2023-11-30) — Purchase Of Investment: 0.00
CCL cash_flow (annual, 2023-11-30) — Purchase Of PPE: -3284000000.00
CCL balance_sheet (annual, 2023-11-30) — Receivables: 556000000.00
CCL income_statement (annual, 2023-11-30) — Reconciled Cost Of Revenue: 14317000000.00
CCL income_statement (annual, 2023-11-30) — Reconciled Depreciation: 2370000000.00
CCL cash_flow (annual, 2023-11-30) — Repayment Of Debt: -7860000000.00
CCL balance_sheet (annual, 2023-11-30) — Restricted Cash: 11000000.00
CCL balance_sheet (annual, 2023-11-30) — Retained Earnings: 185000000.00
CCL cash_flow (annual, 2023-11-30) — Sale Of Investment: 0.00
CCL cash_flow (annual, 2023-11-30) — Sale Of PPE: 340000000.00
CCL income_statement (annual, 2023-11-30) — Selling General And Administration: 2950000000.00
CCL balance_sheet (annual, 2023-11-30) — Share Issued: 1394000000.00
CCL cash_flow (annual, 2023-11-30) — Short Term Debt Payments: -200000000.00
CCL income_statement (annual, 2023-11-30) — Special Income Charges: -111000000.00
CCL cash_flow (annual, 2023-11-30) — Stock Based Compensation: 53000000.00
CCL balance_sheet (annual, 2023-11-30) — Stockholders Equity: 6883000000.00
CCL balance_sheet (annual, 2023-11-30) — Tangible Book Value: 5135000000.00
CCL income_statement (annual, 2023-11-30) — Tax Effect Of Unusual Items: -23310000.00
CCL income_statement (annual, 2023-11-30) — Tax Provision: 13000000.00
CCL income_statement (annual, 2023-11-30) — Tax Rate For Calcs: 0.21
CCL balance_sheet (annual, 2023-11-30) — Total Assets: 49120000000.00
CCL balance_sheet (annual, 2023-11-30) — Total Capitalization: 35366000000.00
CCL balance_sheet (annual, 2023-11-30) — Total Debt: 31891000000.00
CCL balance_sheet (annual, 2023-11-30) — Total Equity Gross Minority Interest: 6883000000.00
CCL income_statement (annual, 2023-11-30) — Total Expenses: 19637000000.00
CCL balance_sheet (annual, 2023-11-30) — Total Liabilities Net Minority Interest: 42237000000.00
CCL balance_sheet (annual, 2023-11-30) — Total Non Current Assets: 43854000000.00
CCL balance_sheet (annual, 2023-11-30) — Total Non Current Liabilities Net Minority Interest: 30756000000.00
CCL income_statement (annual, 2023-11-30) — Total Operating Income As Reported: 1956000000.00
CCL income_statement (annual, 2023-11-30) — Total Unusual Items: -111000000.00
CCL income_statement (annual, 2023-11-30) — Total Unusual Items Excluding Goodwill: -111000000.00
CCL balance_sheet (annual, 2023-11-30) — Treasury Shares Number: 203000000.00
CCL balance_sheet (annual, 2023-11-30) — Treasury Stock: 8449000000.00
CCL balance_sheet (annual, 2023-11-30) — Working Capital: -6215000000.00
CCL income_statement (quarterly, 2024-08-31) — Average Dilution Earnings: 25000000.00
CCL cash_flow (quarterly, 2024-08-31) — Common Stock Issuance: 0.00
CCL cash_flow (quarterly, 2024-08-31) — Earnings Losses From Equity Investments: -10000000.00
CCL cash_flow (quarterly, 2024-08-31) — Gain Loss On Sale Of PPE: -8000000.00
CCL cash_flow (quarterly, 2024-08-31) — Issuance Of Capital Stock: 0.00
CCL cash_flow (quarterly, 2024-08-31) — Net Common Stock Issuance: 0.00
CCL cash_flow (quarterly, 2024-08-31) — Net Short Term Debt Issuance: 0.00
CCL balance_sheet (quarterly, 2024-08-31) — Other Current Liabilities: 1000000.00
CCL cash_flow (quarterly, 2024-08-31) — Proceeds From Stock Option Exercised: 1000000.00
CCL cash_flow (quarterly, 2024-08-31) — Short Term Debt Payments: 0.00
CCL income_statement (annual, 2024-11-30) — +Operating Expense: 5809000000.00
CCL income_statement (annual, 2024-11-30) — +Total Revenue: 25021000000.00
CCL balance_sheet (annual, 2024-11-30) — Accounts Payable: 1133000000.00
CCL balance_sheet (annual, 2024-11-30) — Accounts Receivable: 590000000.00
CCL balance_sheet (annual, 2024-11-30) — Accumulated Depreciation: -22094000000.00
CCL balance_sheet (quarterly, 2024-11-30) — Accumulated Depreciation: -22094000000.00
CCL balance_sheet (annual, 2024-11-30) — Additional Paid In Capital: 17155000000.00
CCL cash_flow (annual, 2024-11-30) — Asset Impairment Charge: 0.00
CCL cash_flow (quarterly, 2024-11-30) — Asset Impairment Charge: -2000000.00
CCL income_statement (annual, 2024-11-30) — Average Dilution Earnings: 94000000.00
CCL income_statement (annual, 2024-11-30) — Basic Average Shares: 1274000000.00
CCL income_statement (annual, 2024-11-30) — Basic EPS: 1.50
CCL cash_flow (annual, 2024-11-30) — Beginning Cash Position: 2436000000.00
CCL cash_flow (annual, 2024-11-30) — Capital Expenditure: -4626000000.00
CCL balance_sheet (annual, 2024-11-30) — Capital Lease Obligations: 1402000000.00
CCL balance_sheet (annual, 2024-11-30) — Capital Stock: 374000000.00
CCL balance_sheet (annual, 2024-11-30) — Cash And Cash Equivalents: 1210000000.00
CCL balance_sheet (annual, 2024-11-30) — Cash Cash Equivalents And Short Term Investments: 1210000000.00
CCL balance_sheet (annual, 2024-11-30) — Cash Equivalents: 1210000000.00
CCL balance_sheet (quarterly, 2024-11-30) — Cash Equivalents: 1210000000.00
CCL cash_flow (annual, 2024-11-30) — Cash Flow From Continuing Financing Activities: -2584000000.00
CCL cash_flow (annual, 2024-11-30) — Cash Flow From Continuing Investing Activities: -4534000000.00
CCL cash_flow (annual, 2024-11-30) — Cash Flow From Continuing Operating Activities: 5922000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Account Payable: -26000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Accrued Expense: 167000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Inventory: 9000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Other Working Capital: 507000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Payable: -26000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Payables And Accrued Expense: 141000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Prepaid Assets: 352000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Receivables: -49000000.00
CCL cash_flow (annual, 2024-11-30) — Change In Working Capital: 960000000.00
CCL cash_flow (annual, 2024-11-30) — Changes In Cash: -1197000000.00
CCL balance_sheet (annual, 2024-11-30) — Common Stock: 374000000.00
CCL balance_sheet (annual, 2024-11-30) — Common Stock Equity: 9252000000.00
CCL cash_flow (annual, 2024-11-30) — Common Stock Issuance: 0.00
CCL cash_flow (quarterly, 2024-11-30) — Common Stock Issuance: 0.00
CCL balance_sheet (annual, 2024-11-30) — Construction In Progress: 535000000.00
CCL balance_sheet (quarterly, 2024-11-30) — Construction In Progress: 535000000.00
CCL income_statement (annual, 2024-11-30) — Cost Of Revenue: 15638000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Accrued Expenses: 2358000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Assets: 3378000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Capital Lease Obligation: 163000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Debt: 1538000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Debt And Capital Lease Obligation: 1701000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Deferred Liabilities: 6425000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Deferred Revenue: 6425000000.00
CCL balance_sheet (annual, 2024-11-30) — Current Liabilities: 11617000000.00
CCL cash_flow (annual, 2024-11-30) — Depreciation Amortization Depletion: 2557000000.00
CCL income_statement (annual, 2024-11-30) — Depreciation Amortization Depletion Income Statement: 2557000000.00
CCL cash_flow (annual, 2024-11-30) — Depreciation And Amortization: 2557000000.00
CCL income_statement (annual, 2024-11-30) — Depreciation And Amortization In Income Statement: 2557000000.00
CCL income_statement (annual, 2024-11-30) — Diluted Average Shares: 1398000000.00
CCL income_statement (annual, 2024-11-30) — Diluted EPS: 1.44
CCL income_statement (annual, 2024-11-30) — Diluted NI Availto Com Stockholders: 2009000000.00
CCL income_statement (annual, 2024-11-30) — EBIT: 3670000000.00
CCL income_statement (annual, 2024-11-30) — EBITDA: 6227000000.00
CCL cash_flow (annual, 2024-11-30) — Earnings Losses From Equity Investments: -9000000.00
CCL cash_flow (quarterly, 2024-11-30) — Earnings Losses From Equity Investments: -6000000.00
CCL cash_flow (annual, 2024-11-30) — Effect Of Exchange Rate Changes: -8000000.00
CCL cash_flow (annual, 2024-11-30) — End Cash Position: 1231000000.00
CCL cash_flow (annual, 2024-11-30) — Financing Cash Flow: -2584000000.00
CCL balance_sheet (annual, 2024-11-30) — Foreign Currency Translation Adjustments: -1955000000.00
CCL balance_sheet (quarterly, 2024-11-30) — Foreign Currency Translation Adjustments: -1955000000.00
CCL cash_flow (annual, 2024-11-30) — Free Cash Flow: 1297000000.00
CCL cash_flow (annual, 2024-11-30) — Gain Loss On Sale Of PPE: -41000000.00
CCL cash_flow (quarterly, 2024-11-30) — Gain Loss On Sale Of PPE: -33000000.00
CCL balance_sheet (annual, 2024-11-30) — Gains Losses Not Affecting Retained Earnings: -1974000000.00
CCL balance_sheet (annual, 2024-11-30) — Goodwill: 579000000.00
CCL balance_sheet (annual, 2024-11-30) — Goodwill And Other Intangible Assets: 1742000000.00
CCL balance_sheet (annual, 2024-11-30) — Gross PPE: 65257000000.00
CCL income_statement (annual, 2024-11-30) — Gross Profit: 9383000000.00
CCL income_statement (annual, 2024-11-30) — Interest Expense: 1755000000.00
CCL income_statement (annual, 2024-11-30) — Interest Expense Non Operating: 1755000000.00
CCL income_statement (annual, 2024-11-30) — Interest Income: 93000000.00
CCL income_statement (annual, 2024-11-30) — Interest Income Non Operating: 93000000.00
CCL balance_sheet (annual, 2024-11-30) — Inventory: 507000000.00
CCL balance_sheet (annual, 2024-11-30) — Invested Capital: 36726000000.00
CCL cash_flow (annual, 2024-11-30) — Investing Cash Flow: -4535000000.00
CCL cash_flow (annual, 2024-11-30) — Issuance Of Capital Stock: 0.00
CCL cash_flow (quarterly, 2024-11-30) — Issuance Of Capital Stock: 0.00
CCL cash_flow (annual, 2024-11-30) — Issuance Of Debt: 3095000000.00
CCL balance_sheet (annual, 2024-11-30) — Long Term Capital Lease Obligation: 1239000000.00
CCL balance_sheet (annual, 2024-11-30) — Long Term Debt: 25936000000.00
CCL balance_sheet (annual, 2024-11-30) — Long Term Debt And Capital Lease Obligation: 27175000000.00
CCL cash_flow (annual, 2024-11-30) — Long Term Debt Issuance: 3095000000.00
CCL cash_flow (annual, 2024-11-30) — Long Term Debt Payments: -5436000000.00
CCL balance_sheet (annual, 2024-11-30) — Machinery Furniture Equipment: 58649000000.00
CCL balance_sheet (quarterly, 2024-11-30) — Machinery Furniture Equipment: 58649000000.00
CCL balance_sheet (annual, 2024-11-30) — Minimum Pension Liabilities: -45000000.00
CCL balance_sheet (quarterly, 2024-11-30) — Minimum Pension Liabilities: -45000000.00
CCL cash_flow (annual, 2024-11-30) — Net Common Stock Issuance: 0.00
CCL cash_flow (quarterly, 2024-11-30) — Net Common Stock Issuance: 0.00
CCL balance_sheet (annual, 2024-11-30) — Net Debt: 26264000000.00
CCL income_statement (annual, 2024-11-30) — Net Income: 1916000000.00
CCL income_statement (annual, 2024-11-30) — Net Income Common Stockholders: 1916000000.00
CCL income_statement (annual, 2024-11-30) — Net Income Continuous Operations: 1916000000.00
CCL income_statement (annual, 2024-11-30) — Net Income From Continuing And Discontinued Operation: 1916000000.00
CCL income_statement (annual, 2024-11-30) — Net Income From Continuing Operation Net Minority Interest: 1916000000.00
CCL cash_flow (annual, 2024-11-30) — Net Income From Continuing Operations: 1916000000.00
CCL income_statement (annual, 2024-11-30) — Net Income Including Noncontrolling Interests: 1916000000.00
CCL income_statement (annual, 2024-11-30) — Net Interest Income: -1662000000.00
CCL cash_flow (annual, 2024-11-30) — Net Investment Purchase And Sale: 0.00
CCL cash_flow (annual, 2024-11-30) — Net Issuance Payments Of Debt: -2341000000.00
CCL cash_flow (annual, 2024-11-30) — Net Long Term Debt Issuance: -2341000000.00
CCL income_statement (annual, 2024-11-30) — Net Non Operating Interest Income Expense: -1662000000.00
CCL cash_flow (annual, 2024-11-30) — Net Other Financing Charges: -243000000.00
CCL cash_flow (annual, 2024-11-30) — Net Other Investing Changes: 33000000.00
CCL balance_sheet (annual, 2024-11-30) — Net PPE: 43163000000.00
CCL cash_flow (annual, 2024-11-30) — Net PPE Purchase And Sale: -4568000000.00
CCL cash_flow (annual, 2024-11-30) — Net Short Term Debt Issuance: 0.00
CCL cash_flow (quarterly, 2024-11-30) — Net Short Term Debt Issuance: 0.00
CCL balance_sheet (annual, 2024-11-30) — Net Tangible Assets: 7510000000.00
CCL income_statement (annual, 2024-11-30) — Normalized EBITDA: 6306000000.00
CCL income_statement (annual, 2024-11-30) — Normalized Income: 1978410000.00
CCL cash_flow (annual, 2024-11-30) — Operating Cash Flow: 5923000000.00
CCL cash_flow (annual, 2024-11-30) — Operating Gains Losses: 35000000.00
CCL cash_flow (quarterly, 2024-11-30) — Operating Gains Losses: -38000000.00
CCL income_statement (annual, 2024-11-30) — Operating Income: 3574000000.00
CCL income_statement (annual, 2024-11-30) — Operating Revenue: 25021000000.00
CCL balance_sheet (annual, 2024-11-30) — Ordinary Shares Number: 1308000000.00
CCL balance_sheet (annual, 2024-11-30) — Other Current Assets: 1071000000.00
CCL balance_sheet (annual, 2024-11-30) — Other Current Borrowings: 1538000000.00
CCL balance_sheet (annual, 2024-11-30) — Other Equity Adjustments: 26000000.00
CCL income_statement (annual, 2024-11-30) — Other Income Expense: 4000000.00
CCL balance_sheet (annual, 2024-11-30) — Other Intangible Assets: 1163000000.00
CCL cash_flow (annual, 2024-11-30) — Other Non Cash Items: 393000000.00
CCL balance_sheet (annual, 2024-11-30) — Other Non Current Assets: 775000000.00
CCL balance_sheet (annual, 2024-11-30) — Other Non Current Liabilities: 1013000000.00
CCL income_statement (annual, 2024-11-30) — Other Non Operating Income Expenses: 83000000.00
CCL balance_sheet (annual, 2024-11-30) — Other Properties: 6073000000.00
CCL income_statement (annual, 2024-11-30) — Other Special Charges: 79000000.00
CCL income_statement (quarterly, 2024-11-30) — Other Special Charges: 1000000.00
CCL balance_sheet (annual, 2024-11-30) — Payables: 1133000000.00
CCL balance_sheet (annual, 2024-11-30) — Payables And Accrued Expenses: 3491000000.00
CCL income_statement (annual, 2024-11-30) — Pretax Income: 1915000000.00
CCL cash_flow (annual, 2024-11-30) — Proceeds From Stock Option Exercised: 0.00
CCL cash_flow (quarterly, 2024-11-30) — Proceeds From Stock Option Exercised: -1000000.00
CCL cash_flow (annual, 2024-11-30) — Purchase Of Investment: 0.00
CCL cash_flow (annual, 2024-11-30) — Purchase Of PPE: -4626000000.00
CCL balance_sheet (annual, 2024-11-30) — Receivables: 590000000.00
CCL income_statement (annual, 2024-11-30) — Reconciled Cost Of Revenue: 15638000000.00
CCL income_statement (annual, 2024-11-30) — Reconciled Depreciation: 2557000000.00
CCL cash_flow (annual, 2024-11-30) — Repayment Of Debt: -5436000000.00
CCL balance_sheet (annual, 2024-11-30) — Retained Earnings: 2101000000.00
CCL cash_flow (annual, 2024-11-30) — Sale Of Investment: 0.00
CCL cash_flow (annual, 2024-11-30) — Sale Of PPE: 58000000.00
CCL income_statement (annual, 2024-11-30) — Selling General And Administration: 3252000000.00
CCL balance_sheet (annual, 2024-11-30) — Share Issued: 1438000000.00
CCL cash_flow (annual, 2024-11-30) — Short Term Debt Payments: 0.00
CCL cash_flow (quarterly, 2024-11-30) — Short Term Debt Payments: 0.00
CCL income_statement (annual, 2024-11-30) — Special Income Charges: -79000000.00
CCL cash_flow (annual, 2024-11-30) — Stock Based Compensation: 62000000.00
CCL balance_sheet (annual, 2024-11-30) — Stockholders Equity: 9252000000.00
CCL balance_sheet (annual, 2024-11-30) — Tangible Book Value: 7510000000.00
CCL income_statement (annual, 2024-11-30) — Tax Effect Of Unusual Items: -16590000.00
CCL income_statement (annual, 2024-11-30) — Tax Provision: -1000000.00
CCL income_statement (annual, 2024-11-30) — Tax Rate For Calcs: 0.21
CCL balance_sheet (annual, 2024-11-30) — Total Assets: 49057000000.00
CCL balance_sheet (annual, 2024-11-30) — Total Capitalization: 35188000000.00
CCL balance_sheet (annual, 2024-11-30) — Total Debt: 28876000000.00
CCL balance_sheet (annual, 2024-11-30) — Total Equity Gross Minority Interest: 9252000000.00
CCL income_statement (annual, 2024-11-30) — Total Expenses: 21447000000.00
CCL balance_sheet (annual, 2024-11-30) — Total Liabilities Net Minority Interest: 39805000000.00
CCL balance_sheet (annual, 2024-11-30) — Total Non Current Assets: 45680000000.00
CCL balance_sheet (annual, 2024-11-30) — Total Non Current Liabilities Net Minority Interest: 28188000000.00
CCL income_statement (annual, 2024-11-30) — Total Operating Income As Reported: 3574000000.00
CCL income_statement (annual, 2024-11-30) — Total Unusual Items: -79000000.00
CCL income_statement (annual, 2024-11-30) — Total Unusual Items Excluding Goodwill: -79000000.00
CCL balance_sheet (annual, 2024-11-30) — Treasury Shares Number: 203000000.00
CCL balance_sheet (annual, 2024-11-30) — Treasury Stock: 8404000000.00
CCL balance_sheet (annual, 2024-11-30) — Working Capital: -8239000000.00
CCL income_statement (quarterly, 2025-02-28) — +Operating Expense: 1502000000.00
CCL income_statement (quarterly, 2025-02-28) — +Total Revenue: 5810000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Accounts Payable: 1091000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Accounts Receivable: 543000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Additional Paid In Capital: 17180000000.00
CCL income_statement (quarterly, 2025-02-28) — Basic Average Shares: 1309000000.00
CCL income_statement (quarterly, 2025-02-28) — Basic EPS: -0.06
CCL cash_flow (quarterly, 2025-02-28) — Beginning Cash Position: 1231000000.00
CCL cash_flow (quarterly, 2025-02-28) — Capital Expenditure: -607000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Capital Lease Obligations: 1373000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Capital Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Cash And Cash Equivalents: 833000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Cash Cash Equivalents And Short Term Investments: 833000000.00
CCL cash_flow (quarterly, 2025-02-28) — Cash Dividends Paid: 0.00
CCL cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Financing Activities: -690000000.00
CCL cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Investing Activities: -605000000.00
CCL cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Operating Activities: 924000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Account Payable: -31000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Accrued Expense: -443000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Inventory: -17000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Other Working Capital: 503000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Payable: -31000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Payables And Accrued Expense: -474000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Prepaid Assets: -64000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Receivables: 33000000.00
CCL cash_flow (quarterly, 2025-02-28) — Change In Working Capital: -19000000.00
CCL cash_flow (quarterly, 2025-02-28) — Changes In Cash: -369000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Common Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Common Stock Equity: 9183000000.00
CCL income_statement (quarterly, 2025-02-28) — Cost Of Revenue: 3766000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Accrued Expenses: 1939000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Assets: 2977000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Capital Lease Obligation: 164000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Debt: 1531000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Debt And Capital Lease Obligation: 1695000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Deferred Liabilities: 6853000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Deferred Revenue: 6853000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Current Liabilities: 11578000000.00
CCL cash_flow (quarterly, 2025-02-28) — Depreciation Amortization Depletion: 654000000.00
CCL income_statement (quarterly, 2025-02-28) — Depreciation Amortization Depletion Income Statement: 654000000.00
CCL cash_flow (quarterly, 2025-02-28) — Depreciation And Amortization: 654000000.00
CCL income_statement (quarterly, 2025-02-28) — Depreciation And Amortization In Income Statement: 654000000.00
CCL income_statement (quarterly, 2025-02-28) — Diluted Average Shares: 1309000000.00
CCL income_statement (quarterly, 2025-02-28) — Diluted EPS: -0.06
CCL income_statement (quarterly, 2025-02-28) — Diluted NI Availto Com Stockholders: -78000000.00
CCL income_statement (quarterly, 2025-02-28) — EBIT: 309000000.00
CCL income_statement (quarterly, 2025-02-28) — EBITDA: 963000000.00
CCL cash_flow (quarterly, 2025-02-28) — Earnings Losses From Equity Investments: 2000000.00
CCL cash_flow (quarterly, 2025-02-28) — Effect Of Exchange Rate Changes: -6000000.00
CCL cash_flow (quarterly, 2025-02-28) — End Cash Position: 856000000.00
CCL cash_flow (quarterly, 2025-02-28) — Financing Cash Flow: -690000000.00
CCL cash_flow (quarterly, 2025-02-28) — Free Cash Flow: 318000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Gains Losses Not Affecting Retained Earnings: -1986000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Goodwill: 579000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Goodwill And Other Intangible Assets: 1741000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Gross PPE: 42995000000.00
CCL income_statement (quarterly, 2025-02-28) — Gross Profit: 2044000000.00
CCL income_statement (quarterly, 2025-02-28) — Interest Expense: 377000000.00
CCL income_statement (quarterly, 2025-02-28) — Interest Expense Non Operating: 377000000.00
CCL income_statement (quarterly, 2025-02-28) — Interest Income: 7000000.00
CCL income_statement (quarterly, 2025-02-28) — Interest Income Non Operating: 7000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Inventory: 518000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Invested Capital: 36201000000.00
CCL cash_flow (quarterly, 2025-02-28) — Investing Cash Flow: -605000000.00
CCL cash_flow (quarterly, 2025-02-28) — Issuance Of Debt: 2980000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Long Term Capital Lease Obligation: 1209000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Long Term Debt: 25487000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Long Term Debt And Capital Lease Obligation: 26696000000.00
CCL cash_flow (quarterly, 2025-02-28) — Long Term Debt Issuance: 2980000000.00
CCL cash_flow (quarterly, 2025-02-28) — Long Term Debt Payments: -3448000000.00
CCL income_statement (quarterly, 2025-02-28) — Minority Interests: -4000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Net Debt: 26185000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Income: -78000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Income Common Stockholders: -78000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Income Continuous Operations: -75000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Income From Continuing And Discontinued Operation: -78000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Income From Continuing Operation Net Minority Interest: -78000000.00
CCL cash_flow (quarterly, 2025-02-28) — Net Income From Continuing Operations: -75000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Income Including Noncontrolling Interests: -75000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Interest Income: -370000000.00
CCL cash_flow (quarterly, 2025-02-28) — Net Issuance Payments Of Debt: -468000000.00
CCL cash_flow (quarterly, 2025-02-28) — Net Long Term Debt Issuance: -468000000.00
CCL income_statement (quarterly, 2025-02-28) — Net Non Operating Interest Income Expense: -370000000.00
CCL cash_flow (quarterly, 2025-02-28) — Net Other Financing Charges: -222000000.00
CCL cash_flow (quarterly, 2025-02-28) — Net Other Investing Changes: -9000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Net PPE: 42995000000.00
CCL cash_flow (quarterly, 2025-02-28) — Net PPE Purchase And Sale: -596000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Net Tangible Assets: 7442000000.00
CCL income_statement (quarterly, 2025-02-28) — Normalized EBITDA: 1215000000.00
CCL income_statement (quarterly, 2025-02-28) — Normalized Income: 121080000.00
CCL cash_flow (quarterly, 2025-02-28) — Operating Cash Flow: 925000000.00
CCL cash_flow (quarterly, 2025-02-28) — Operating Gains Losses: 249000000.00
CCL income_statement (quarterly, 2025-02-28) — Operating Income: 542000000.00
CCL income_statement (quarterly, 2025-02-28) — Operating Revenue: 5810000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Ordinary Shares Number: 1311000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Other Current Assets: 1083000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Other Current Borrowings: 1531000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Other Equity Adjustments: -1986000000.00
CCL income_statement (quarterly, 2025-02-28) — Other Income Expense: -240000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Other Intangible Assets: 1162000000.00
CCL cash_flow (quarterly, 2025-02-28) — Other Non Cash Items: 98000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Other Non Current Assets: 822000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Other Non Current Liabilities: 1078000000.00
CCL income_statement (quarterly, 2025-02-28) — Other Non Operating Income Expenses: 12000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Other Properties: 42995000000.00
CCL income_statement (quarterly, 2025-02-28) — Other Special Charges: 252000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Payables: 1091000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Payables And Accrued Expenses: 3030000000.00
CCL income_statement (quarterly, 2025-02-28) — Pretax Income: -68000000.00
CCL cash_flow (quarterly, 2025-02-28) — Purchase Of PPE: -607000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Receivables: 543000000.00
CCL income_statement (quarterly, 2025-02-28) — Reconciled Cost Of Revenue: 3766000000.00
CCL income_statement (quarterly, 2025-02-28) — Reconciled Depreciation: 654000000.00
CCL cash_flow (quarterly, 2025-02-28) — Repayment Of Debt: -3448000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Retained Earnings: 1991000000.00
CCL cash_flow (quarterly, 2025-02-28) — Sale Of PPE: 11000000.00
CCL income_statement (quarterly, 2025-02-28) — Selling General And Administration: 848000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Share Issued: 1442000000.00
CCL income_statement (quarterly, 2025-02-28) — Special Income Charges: -252000000.00
CCL cash_flow (quarterly, 2025-02-28) — Stock Based Compensation: 18000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Stockholders Equity: 9183000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Tangible Book Value: 7442000000.00
CCL income_statement (quarterly, 2025-02-28) — Tax Effect Of Unusual Items: -52920000.00
CCL income_statement (quarterly, 2025-02-28) — Tax Provision: 7000000.00
CCL income_statement (quarterly, 2025-02-28) — Tax Rate For Calcs: 0.21
CCL balance_sheet (quarterly, 2025-02-28) — Total Assets: 48535000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Total Capitalization: 34670000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Total Debt: 28391000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Total Equity Gross Minority Interest: 9183000000.00
CCL income_statement (quarterly, 2025-02-28) — Total Expenses: 5268000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Total Liabilities Net Minority Interest: 39352000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Total Non Current Assets: 45558000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Total Non Current Liabilities Net Minority Interest: 27774000000.00
CCL income_statement (quarterly, 2025-02-28) — Total Operating Income As Reported: 543000000.00
CCL income_statement (quarterly, 2025-02-28) — Total Unusual Items: -252000000.00
CCL income_statement (quarterly, 2025-02-28) — Total Unusual Items Excluding Goodwill: -252000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Treasury Shares Number: 203000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Treasury Stock: 8376000000.00
CCL balance_sheet (quarterly, 2025-02-28) — Working Capital: -8601000000.00
CCL income_statement (quarterly, 2025-05-31) — +Operating Expense: 1508000000.00
CCL income_statement (quarterly, 2025-05-31) — +Total Revenue: 6328000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Accounts Payable: 1198000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Accounts Receivable: 569000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Additional Paid In Capital: 17208000000.00
CCL income_statement (quarterly, 2025-05-31) — Average Dilution Earnings: 18000000.00
CCL income_statement (quarterly, 2025-05-31) — Basic Average Shares: 1312000000.00
CCL income_statement (quarterly, 2025-05-31) — Basic EPS: 0.43
CCL cash_flow (quarterly, 2025-05-31) — Beginning Cash Position: 856000000.00
CCL cash_flow (quarterly, 2025-05-31) — Capital Expenditure: -851000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Capital Lease Obligations: 1394000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Capital Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Cash And Cash Equivalents: 2146000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Cash Cash Equivalents And Short Term Investments: 2146000000.00
CCL cash_flow (quarterly, 2025-05-31) — Cash Dividends Paid: 0.00
CCL cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Financing Activities: -520000000.00
CCL cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Investing Activities: -586000000.00
CCL cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Operating Activities: 2395000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Account Payable: 21000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Accrued Expense: 61000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Inventory: 50000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Other Working Capital: 1093000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Payable: 21000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Payables And Accrued Expense: 82000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Prepaid Assets: -145000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Receivables: -11000000.00
CCL cash_flow (quarterly, 2025-05-31) — Change In Working Capital: 1069000000.00
CCL cash_flow (quarterly, 2025-05-31) — Changes In Cash: 1285000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Common Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 10008000000.00
CCL income_statement (quarterly, 2025-05-31) — Cost Of Revenue: 3886000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Accrued Expenses: 2072000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Assets: 4349000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Capital Lease Obligation: 177000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Debt: 1392000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Debt And Capital Lease Obligation: 1569000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Deferred Liabilities: 8082000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Deferred Revenue: 8082000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Current Liabilities: 12920000000.00
CCL cash_flow (quarterly, 2025-05-31) — Depreciation Amortization Depletion: 692000000.00
CCL income_statement (quarterly, 2025-05-31) — Depreciation Amortization Depletion Income Statement: 692000000.00
CCL cash_flow (quarterly, 2025-05-31) — Depreciation And Amortization: 692000000.00
CCL income_statement (quarterly, 2025-05-31) — Depreciation And Amortization In Income Statement: 692000000.00
CCL income_statement (quarterly, 2025-05-31) — Diluted Average Shares: 1400000000.00
CCL income_statement (quarterly, 2025-05-31) — Diluted EPS: 0.42
CCL income_statement (quarterly, 2025-05-31) — Diluted NI Availto Com Stockholders: 582000000.00
CCL income_statement (quarterly, 2025-05-31) — EBIT: 926000000.00
CCL income_statement (quarterly, 2025-05-31) — EBITDA: 1618000000.00
CCL cash_flow (quarterly, 2025-05-31) — Earnings Losses From Equity Investments: 1000000.00
CCL cash_flow (quarterly, 2025-05-31) — Effect Of Exchange Rate Changes: 30000000.00
CCL cash_flow (quarterly, 2025-05-31) — End Cash Position: 2171000000.00
CCL cash_flow (quarterly, 2025-05-31) — Financing Cash Flow: -521000000.00
CCL cash_flow (quarterly, 2025-05-31) — Free Cash Flow: 1541000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Gains Losses Not Affecting Retained Earnings: -1753000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Goodwill: 579000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Goodwill And Other Intangible Assets: 1757000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Gross PPE: 44116000000.00
CCL income_statement (quarterly, 2025-05-31) — Gross Profit: 2442000000.00
CCL income_statement (quarterly, 2025-05-31) — Interest Expense: 341000000.00
CCL income_statement (quarterly, 2025-05-31) — Interest Expense Non Operating: 341000000.00
CCL income_statement (quarterly, 2025-05-31) — Interest Income: 12000000.00
CCL income_statement (quarterly, 2025-05-31) — Interest Income Non Operating: 12000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Inventory: 476000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Invested Capital: 37262000000.00
CCL cash_flow (quarterly, 2025-05-31) — Investing Cash Flow: -586000000.00
CCL cash_flow (quarterly, 2025-05-31) — Issuance Of Debt: 1102000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Long Term Capital Lease Obligation: 1217000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Long Term Debt: 25862000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 27079000000.00
CCL cash_flow (quarterly, 2025-05-31) — Long Term Debt Issuance: 1102000000.00
CCL cash_flow (quarterly, 2025-05-31) — Long Term Debt Payments: -1616000000.00
CCL income_statement (quarterly, 2025-05-31) — Minority Interests: -4000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Net Debt: 25108000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Income: 565000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Income Common Stockholders: 565000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Income Continuous Operations: 568000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 565000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 565000000.00
CCL cash_flow (quarterly, 2025-05-31) — Net Income From Continuing Operations: 569000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Income Including Noncontrolling Interests: 568000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Interest Income: -329000000.00
CCL cash_flow (quarterly, 2025-05-31) — Net Issuance Payments Of Debt: -514000000.00
CCL cash_flow (quarterly, 2025-05-31) — Net Long Term Debt Issuance: -514000000.00
CCL income_statement (quarterly, 2025-05-31) — Net Non Operating Interest Income Expense: -329000000.00
CCL cash_flow (quarterly, 2025-05-31) — Net Other Financing Charges: -7000000.00
CCL cash_flow (quarterly, 2025-05-31) — Net Other Investing Changes: -36000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Net PPE: 44116000000.00
CCL cash_flow (quarterly, 2025-05-31) — Net PPE Purchase And Sale: -550000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 8251000000.00
CCL income_statement (quarterly, 2025-05-31) — Normalized EBITDA: 1622000000.00
CCL income_statement (quarterly, 2025-05-31) — Normalized Income: 568883760.68
CCL cash_flow (quarterly, 2025-05-31) — Operating Cash Flow: 2392000000.00
CCL cash_flow (quarterly, 2025-05-31) — Operating Gains Losses: -99000000.00
CCL income_statement (quarterly, 2025-05-31) — Operating Income: 934000000.00
CCL income_statement (quarterly, 2025-05-31) — Operating Revenue: 6328000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 1312000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Current Assets: 1158000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Current Borrowings: 1392000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Current Liabilities: -1000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Equity Adjustments: -1753000000.00
CCL income_statement (quarterly, 2025-05-31) — Other Income Expense: -20000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Intangible Assets: 1178000000.00
CCL cash_flow (quarterly, 2025-05-31) — Other Non Cash Items: 134000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Non Current Assets: 943000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Non Current Liabilities: 1158000000.00
CCL income_statement (quarterly, 2025-05-31) — Other Non Operating Income Expenses: -16000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Other Properties: 44116000000.00
CCL income_statement (quarterly, 2025-05-31) — Other Special Charges: 4000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Payables: 1198000000.00